Skip to main navigation menu Skip to main content Skip to site footer

Technical comment

Vol. 144 No. 1516 (2014)

Early detection of urinary NGAL and plasma CysC may prevent progression to overt acute renal failure

  • Hakan Sarlak
  • Mustafa Dinc
  • Sevket Balta
  • Mustafa Cakar
  • Erol Arslan
  • Seref Demirbas
DOI
https://doi.org/10.4414/smw.2014.13949
Cite this as:
Swiss Med Wkly. 2014;144:w13949
Published
06.04.2014

References

  1. Seitz S, Rauh M, Gloeckler M, et al. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery. Swiss Med Wkly. 2013;143: w13744 http://www.smw.ch/content/smw-2013-13744/.
  2. Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012;142:w13608 http://www.smw.ch/content/smw-2012-13608/.
  3. Riccia Z, Roncob C. New insights in acute kidney failure in the critically ill. Swiss Med Wkly. 2012;142:w13662 http://www.smw.ch/content/smw-2012-13662/.
  4. Kocha AM, Dittricha S, Cesnjevarb R, et al. Plasma neutrophil gelatinase-associated lipocalin measured in consecutive patients after congenital heart surgery using point-of-care technology. Interact Cardiovasc Thorac Surg. 2011;13:133–6.
  5. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009;4:337–44.

Most read articles by the same author(s)